Creso Pharma (ASX: CPH)

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following segments: Creso Pharma Switzerland GmbH in Switzerland, Kunna S.A.S. located in Colombia, Creso Pharma Limited in Australia and other. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.